#United States #Washington #Patient Advocacy #Medicare Bids #Health Supplies

Launch of the 'High Cost of Low Bids' Campaign

In an urgent call to action, a consortium of national patient advocacy organizations has announced the launch of the "High Cost of Low Bids" campaign. This initiative is designed to pressure policymakers to reconsider the inclusion of vital urological and ostomy supplies in Medicare's competitive bidding program. As new regulations set to take effect in January 2028 pose significant threats to supply access, advocates spotlight urgent concerns surrounding patient care and safety.

The campaign's impetus stems from a decision made by the Centers for Medicare & Medicaid Services (CMS), which aims to incorporate these essential supplies into a lowest-bid purchasing framework. However, many experts warn that such a model, particularly for these complex, individualized products, may severely limit access for those in need, ultimately leading to increased healthcare complications and costs.

Millions of Americans depend daily on urological and ostomy supplies due to various health issues, including Spina Bifida, multiple sclerosis, spinal cord injuries, cancer, and inflammatory bowel disease. These supplies are intricately tailored to fit individual patients' anatomical, diagnostic, and lifestyle needs, emphasizing the necessity for personalized care.

Historically, Congress has resisted including these critical products in competitive bidding processes. The 2003 Medicare Modernization Act explicitly excluded them due to their complexities and the potential for severe complications, including infections. Yet, the CMS appears poised to reverse this protective stance, sparking outcry from healthcare advocates who fear that patient safety may not be adequately safeguarded under the forthcoming changes.

Sara Struwe, President and CEO of the Spina Bifida Association, voiced the crux of the issue: "Patients need the right fit – not the lowest bid." She emphasized that the correct supplies are essential for maintaining health and dignity for individuals with complex medical conditions. The shift towards a bidding system without verifiable evidence for safeguarding patient access endangers vulnerable groups.

At present, Medicare engages with numerous suppliers across the United States for ostomy and urological products. However, it is estimated that transitioning to competitive bidding could shrink this number to under ten national suppliers. This consolidation presents a stark risk of reducing product diversity and complicating the process for patients needing specific supplies. Furthermore, local suppliers, which play a crucial role in ensuring timely deliveries of essential products, could be entirely eliminated, especially impacting patients residing in rural regions.

The implications of restricted access could have dire health consequences. Choosing the right products requires comprehensive clinical assessments, and limiting access to a narrower product range risks adverse effects such as leakage, skin breakdown, and potential infections, which could lead to unnecessary emergency room visits. Advocates argue that any short-term savings from such limitations could be quickly outstripped by the resultant healthcare costs stemming from complications.

The "High Cost of Low Bids" campaign consists of both national and regional organizations, all seeking to convey a united message to Congress and the Administration. They implore lawmakers to postpone the implementation of competitive bidding on these essential supplies and demand that the CMS demonstrates its ability to maintain timely access to necessary products, uphold supplier choice, ensure product quality, and support clinician-directed care.

To join this vital cause and to advocate for patient access, individuals are encouraged to visit highcostoflowbids.org. There, they can send messages to Congress emphasizing the importance of a formal review process to safeguard access to these crucial medical supplies before integrating them into the competitive bidding landscape.

This campaign underscores a vital intersection of healthcare policy and patient rights, affirmatively calling upon policymakers to prioritize the health and well-being of those who rely on these life-sustaining supplies.